CB
CSTL icon

Commerce Bank’s Castle Biosciences CSTL Stock Holding History

Commerce Bank’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-5,260
Closed -$236K – 1156
2022
Q1 		$236K Hold
5,260
– – ﹤0.01% 1081
2021
Q4 		$226K Buy
+5,260
New +$275K ﹤0.01% 1116
2021
Q3 		– Sell
-3,205
Closed -$235K – 1164
2021
Q2 		$235K Sell
3,205
-10
-0.3% -$661 ﹤0.01% 1085
2021
Q1 		$221K Sell
3,215
-60
-2% -$4.51K ﹤0.01% 1075
2020
Q4 		$220K Buy
+3,275
New +$178K ﹤0.01% 1021

Other funds holding CSTL

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Commerce Bank's CSTL Position: Q2 2022 in Review

Commerce Bank sold out of Castle Biosciences (CSTL) in Q2 2022, closing a stake of 5,260 shares — an estimated $236K sold.

Commerce Bank first reported a position in CSTL in Q4 2020 and held it in 5 quarters. The position peaked at $236K in Q1 2022. 146 funds tracked by Wall St. Rank hold CSTL as of Q2 2022.

  • Commerce Bank reported no remaining Castle Biosciences position as of Q2 2022 after selling out during the quarter.
  • Commerce Bank sold 5,260 Castle Biosciences shares in Q2 2022, an estimated $236K.
  • Commerce Bank first reported a position in Castle Biosciences in Q4 2020 and held it in 5 quarters.
  • Commerce Bank's Castle Biosciences position peaked at $236K in Q1 2022.
  • 146 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2022.

Based on Commerce Bank's 13F filing for Q2 2022, filed 12 Aug 2022.